Monthly Archives: February 2024

//February

Pharmacy Contraception Service: Updates

Last day to opt-in Pharmacy owners providing the Tier 1 (on-going supply) Pharmacy Contraception Service (PCS), who have not yet confirmed they are ready to provide the expanded service (i.e. initiation and repeat supply), have until 11.59pm tomorrow (Thursday 29th February 2024) to opt-in to the service by making a declaration on the NHS Business [...]

The post Pharmacy Contraception Service: Updates appeared first on Community Pharmacy England.

By |February 28th, 2024|Lexpos News|Comments Off on Pharmacy Contraception Service: Updates

Coalition calls for testing to tackle threat of AMR

Community Pharmacy England has joined a new coalition of industry and health charities, led by the British In Vitro Diagnostics Association (BIVDA) and former Health Minister Maggie Throup MP, to highlight missed opportunities to tackle Antimicrobial Resistance (AMR). Coming together to set out a call to action for the Government and the NHS, the cross-sector [...]

The post Coalition calls for testing to tackle threat of AMR appeared first on Community Pharmacy England.

By |February 27th, 2024|Lexpos News|Comments Off on Coalition calls for testing to tackle threat of AMR

Medicine Supply Notification: Midazolam (Epistatus® ) 5mg/0.5ml oromucosal solution pre-filled oral syringes

Department of Health and Social Care (DHSC) has issued a medicine supply notification for Midazolam (Epistatus®) 5mg/0.5ml oromucosal solution pre-filled oral syringes. MSN/2024/025 Tier 2 – medium impact Date of issue: 27th February 2024 Midazolam (Epistatus®) 5mg/0.5ml oromucosal solution pre-filled oral syringes are currently out of stock. Resupply date of this product is to be [...]

The post Medicine Supply Notification: Midazolam (Epistatus® ) 5mg/0.5ml oromucosal solution pre-filled oral syringes appeared first on Community Pharmacy England.

By |February 27th, 2024|Lexpos News|Comments Off on Medicine Supply Notification: Midazolam (Epistatus® ) 5mg/0.5ml oromucosal solution pre-filled oral syringes

Drug Tariff Watch – March 2024

The Drug Tariff Preface published monthly lists additions, deletions and other changes to products listed in the Drug Tariff. Below is a summary of the changes coming into effect from 1 March 2024. Contractors should note changes made to Part II – Requirements enabling payments to be made for the supply of drugs, appliances and chemical [...]

The post Drug Tariff Watch – March 2024 appeared first on Community Pharmacy England.

By |February 27th, 2024|Lexpos News|Comments Off on Drug Tariff Watch – March 2024

MHRA Class 4 Medicines Defect Information: Concerta® XL 18mg & 36 mg prolonged release tablets (Orifarm UK Ltd)

Class 4 Medicines Defect Information: Concerta® XL 18mg & 36 mg prolonged release tablets (Orifarm UK Ltd) Drug alert number: EL (24)A/07 Date issued: 26 February 2024 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 4 medicines defect information notice for: Concerta® XL 18mg & 36 mg prolonged release tablets (Orifarm [...]

The post MHRA Class 4 Medicines Defect Information: Concerta® XL 18mg & 36 mg prolonged release tablets (Orifarm UK Ltd) appeared first on Community Pharmacy England.

By |February 26th, 2024|Lexpos News|Comments Off on MHRA Class 4 Medicines Defect Information: Concerta® XL 18mg & 36 mg prolonged release tablets (Orifarm UK Ltd)